Literature DB >> 22465889

Anxiety and depression among traumatic spinal cord injured patients.

Rafat M Al-Owesie1, Nehmat M Moussa, Asirvatham A Robert.   

Abstract

OBJECTIVE: To investigate the relation between gender, sociodemographic factors, pain, smoking, and the level of anxiety and depressive symptoms after traumatic spinal cord injury (TSCI) in a Saudi sample.
METHODS: We conducted a cross-sectional study from November 2009 to April 2011, in 102 (age range 17-70 years; 84 males, 18 females) TSCI patients admitted to the Spinal Cord Injury Unit, Sultan Bin Abdulaziz Humanitarian City, Riyadh, Saudi Arabia. We used the Hospital Anxiety and Depression Scale (HADS) to measure the level of anxiety and depression of the study population. The demographic variables were recorded.
RESULTS: Compared to male TSCI patients, the level of anxiety (p=0.0001), depression (p=0.0045), and total HADS (p=0.0002) scores were significantly higher in females. The correlation between level of education and anxiety and depression showed that patients with a university education had higher anxiety (p=0.0115), depression (p=0.0437), and total HADS (p=0.0272) than patients with a lower education level. The TSCI patients with pain reported more anxiety and depression than patients who did not have pain. Compared to non-smokers, the smokers showed marked but insignificant higher levels of anxiety and depression.
CONCLUSION: Women with TSCI are at a significantly higher risk of having anxiety and depressive symptoms. Level of university education was modestly correlated with higher level anxiety and depression in this population.

Entities:  

Mesh:

Year:  2012        PMID: 22465889

Source DB:  PubMed          Journal:  Neurosciences (Riyadh)        ISSN: 1319-6138            Impact factor:   0.906


  8 in total

1.  Hellenic Spinal Cord Section of the Hellenic Society of Physical and Rehabilitation Medicine National Congress 2019, "Healthy, and long living after SCI" Proceedings. 13th-15th December 2019, Vellideio, Thessaloniki, Greece.

Authors: 
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-12-01       Impact factor: 2.041

2.  Does religious coping and spirituality have a moderating role on depression and anxiety in patients with spinal cord injury? A study from Iran.

Authors:  P Rahnama; A N Javidan; H Saberi; A Montazeri; S Tavakkoli; A H Pakpour; M Hajiaghababaei
Journal:  Spinal Cord       Date:  2015-06-30       Impact factor: 2.772

3.  Evaluation of a specialized yoga program for persons with a spinal cord injury: a pilot randomized controlled trial.

Authors:  Kathryn Curtis; Sander L Hitzig; Gitte Bechsgaard; Candice Stoliker; Charlene Alton; Nicole Saunders; Nicole Leong; Joel Katz
Journal:  J Pain Res       Date:  2017-05-03       Impact factor: 3.133

4.  Association of psychological variants with functional outcomes among people with spinal cord injury.

Authors:  Mohammed Qasheesh; Mohammad Abu Shaphe; Amir Iqbal; Ahmad H Alghadir
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

5.  Identification of Mood and Body Mass Index as Modifiable Factors for Health Improvement in Spinal Cord Injury.

Authors:  Ruby Aikat; Varsha Singh
Journal:  Arch Rehabil Res Clin Transl       Date:  2021-12-09

Review 6.  Traumatic spinal cord injury in Saudi Arabia: a review of the literature.

Authors:  Asirvatham Alwin Robert; Marwan M Zamzami
Journal:  Pan Afr Med J       Date:  2013-11-18

7.  What are the people's attitudes toward spinal cord injury victims (from common to elite).

Authors:  Zahra Hosseinigolafshani; Heidarali Abedi; Fazlolah Ahmadi
Journal:  Iran J Nurs Midwifery Res       Date:  2014-05

8.  NeuroRegen Scaffolds Combined with Autologous Bone Marrow Mononuclear Cells for the Repair of Acute Complete Spinal Cord Injury: A 3-Year Clinical Study.

Authors:  Wugui Chen; Ying Zhang; Sizhen Yang; Jing Sun; Hao Qiu; Xu Hu; Xiaojian Niu; Zhifeng Xiao; Yannan Zhao; Yue Zhou; Jianwu Dai; Tongwei Chu
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.